Oorsprong van het eerstegraads netwerk van Thaedra Thullberry
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thaedra Thullberry via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ATHIRA PHARMA, INC. | Biotechnology | Chief Executive Officer | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Investor Relations Contact | |
| Colby College | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Santa Cruz | College/University | Undergraduate Degree | |
| University of Stockholm | College/University | Doctorate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| The Warren Alpert Medical School | College/University | Doctorate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor | |
Dendreon Pharmaceuticals, Inc.
 Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Lumen Bioscience, Inc.
 Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Pharmaceuticals: Other | Director/Board Member | |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Packaged Software | Chairman Director of Finance/CFO | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Founder | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| Zylem Biosciences, Inc. | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 3 |
| Zweden | 2 |
| Nederland | 2 |
| China | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 178 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 46 |
| Founder | 32 |
| Chief Tech/Sci/R&D Officer | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 61 |
| James Topper | 49 |
| Peter Thompson | 39 |
| Xiang Ming Cui | 31 |
| Jay Venkatesan | 30 |
| Robert Conway | 21 |
| R. Carruthers | 15 |
| Mitchell Gold | 15 |
| Andrew Sandler | 12 |
| Mark Litton | 11 |
| Christopher Peetz | 11 |
| Wayne Gombotz | 9 |
| Jörn Drappa | 9 |
| Stanford Peng | 9 |
| James Rickey | 8 |
- Beurs
- Insiders
- Thaedra Thullberry
- Bedrijfsconnecties
